Passa al contenuto
Merck
Tutte le immagini(7)

Documenti

GE17-3717-02

Capto S ImpAct

Cytiva 17-3717-02, pack of 100 ml

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali


About This Item

Codice UNSPSC:
23151817
NACRES:
NA.56

ligand

(-SO3)

Produttore/marchio commerciale

Cytiva 17-3717-02

Matrice

high-flow agarose

Dimens. media delle particelle

50 μm (d50V)

cleaning in place

4-12

working range

3-14

Capacità

binding capacity(>85 mg BSA/mL medium, >90 mg lysozyme/ml medium, >100 mg IgG/ ml medium)

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Descrizione generale

This chromatography medium is part of our platform of high-resolution media based on the Capto product line. The polymeric ligand, in combination with the attributes of the base matrix, gives this cation exchanger a high binding capacity. Furthermore, the small bead size enables high-resolution purifications.

The high-flow characteristics of Capto media allows for excellent pressure-flow properties. The exceptional binding capacity and resolution of Capto S ImpAct, combined with the ability to run at high flow rates and bed heights, increase productivity and flexibility in process design.

Capto S ImpAct is a BioProcess chromatography medium developed for large-scale purification of biopharmaceutical proteins. Based on the well-established Capto base matrix, it provides many opportunities for improved productivity and straightforward process development.

Capto S ImpAct is available in a range of different bulk pack sizes and convenient prepacked formats for easy scale-up and process development. As a member of the BioProcess media range, Capto S ImpAct meets industrial demands with security of supply and comprehensive technical and regulatory support.

Caratteristiche e vantaggi

Capto S ImpAct is a strong cation exchange chromatography medium (resin) developed for intermediate purification and polishing of monoclonal antibodies (MAbs) and other biomolecules.

  • High binding capacity, > 100 mg MAb/mL medium.
  • Efficient aggregate removal at high load of monoclonal antibodies.
  • High-resolution intermediate purification and polishing based on the well-established Capto platform.
  • Flexibility of design thanks to a large operational window of flow rates and bed heights for easy optimization and scaling.
  • High productivity enabling cost-efficient manufacturing.
  • Security of supply and comprehensive regulatory support.

Risultati analitici

To view the Certificate of Analysis for this product, please visit www.cytiva.com.

Note legali

Capto is a trademark of Cytiva

Codice della classe di stoccaggio

3 - Flammable liquids


Certificati d'analisi (COA)

Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.